International Business Machines Corp. (NYSE:IBM)’s Watson is the supercomputer with artificial intelligence, which has the capability of answering the questions in natural languages. IBM recently made an announcement that Watson will be assisting scientists in R&D. John Gordon, VP of IBM Watson Group talked on Fox Business about the new venture.
Gordon said that Watson is venturing into R&D with its cognitive computing to explore a $6 billion opportunity in the R&D market. He assured that there might be a new era of human innovation through this venture. He pointed out that the supercomputer will assist the scientists in developing new ideas for the future.
International Business Machines Corp. (NYSE:IBM)’s Watson was initially developed as a standalone system, which was answering questions posed to it. But, later it was integrated into the cloud, which made it available to everyone. Gordon mentioned that around 2,500 entrepreneurs and companies are looking at the possibility of Watson innovating things for the future of their organizations.
“The first place we put this is in an area of life sciences. So what we are trying to do is, Baylor showed they could find new ways to target proteins that help to really suppress cancer mutations. They found new ways to do it, that we have never known, and they used Watson, not to give them answers, but how to address questions that no one know how to do before,” Gordon said.
Gordon also talked about Watson helping Johnson & Johnson (NYSE:JNJ) to develop medicines. He pointed out that the companies are utilizing International Business Machines Corp. (NYSE:IBM)’s Watson to understand and consolidate the published outcomes and come up with a new idea to do things. He said that it might be difficult for a human to read all the publications and connect them together, but a supercomputer like Watson could do it effortlessly.
Gordon said that Baylor has published a peer-reviews study, which was done in a week with the help of Watson. Baylor also mentioned in the study that the same work would have taken a year otherwise. He mentioned that International Business Machines Corp. (NYSE:IBM) might not just target new innovations in life sciences, but also would help companies in commercializing them. He mentioned that the Watson would also cater into other areas like Energy and bio-fuels in future.
One of the largest shareholders of International Business Machines Corp. (NYSE:IBM) is Berkshire Hathaway, managed by Warren Buffett. They hold around 70.1 million IBM shares as of the end of second quarter.